Literature DB >> 6266702

Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.

S Beer, M Tieder, D Kohelet, O A Liberman, E Vure, G Bar-Joseph, D Gabizon, Z U Borochowitz, M Varon, D Modai.   

Abstract

A 4-year-old girl presented with severe clinical and radiological rickets, and alopecia since the age of 1 year. Laboratory studies revealed: hypocalcaemia, hypophosphataemia, secondary hyperparathyroidism, abnormally low intestinal calcium absorption, and markedly elevated circulating 1,25(OH)2D3 levels. A normal calcaemic response to parathyroid extract was obtained. Treatment attempts with vitamin D2, 1 alpha (OH)D3 and 1,25(OH)2D3 were totally ineffective. Intestinal resistance to the action of 1,25(OH)2D3 appeared well established in this case. Refractoriness of bone to this hormone seems less certain. From this new entity of 'Vitamin D resistant rickets due to end organ unresponsiveness', six cases have been hitherto reported in the literature. However, only two have enough resemblance to our case, to constitute a distinct and well defined nosologic subunit. The molecular basis of this disorder(s) remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266702     DOI: 10.1111/j.1365-2265.1981.tb00626.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia.

Authors:  Y C Li; A E Pirro; M Amling; G Delling; R Baron; R Bronson; M B Demay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Two siblings with a novel nonsense mutation, p.R50X, in the vitamin D receptor gene.

Authors:  Vichit Supornsilchai; Yodporn Hiranras; Suttipong Wacharasindhu; Atchara Mahayosnond; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Endocrine       Date:  2011-03-18       Impact factor: 3.633

3.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

4.  Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.

Authors:  S Balsan; M Garabédian; M Larchet; A M Gorski; G Cournot; C Tau; A Bourdeau; C Silve; C Ricour
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.

Authors:  P J Malloy; Z Hochberg; D Tiosano; J W Pike; M R Hughes; D Feldman
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families.

Authors:  H H Ritchie; M R Hughes; E T Thompson; P J Malloy; Z Hochberg; D Feldman; J W Pike; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

8.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.

Authors:  U A Liberman; C Eil; S J Marx
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

9.  Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.

Authors:  G T Gamblin; U A Liberman; C Eil; R W Downs; D A DeGrange; S J Marx
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

10.  Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.

Authors:  J E Griffin; J E Zerwekh
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.